Testing effectiveness (Phase 2)Study completedNCT00252746What this trial is testingZD6474 Phase IIa Dose Finding Multicentre StudyWho this might be right forNon Small Cell Lung Carcinoma Genzyme, a Sanofi Company 53
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Testing effectiveness (Phase 2)UnknownNCT04742153What this trial is testingMRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC)Who this might be right forAdvanced or Metastatic Breast Cancer Shanghai Miracogen Inc. 66
Not applicableStudy completedNCT03087903What this trial is testingGrape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSAWho this might be right forProstate Cancer University of Colorado, Denver 41
Testing effectiveness (Phase 2)Looking for participantsNCT06668103What this trial is testingClinical Study of Combination Therapy With ABSK043 and FirmonertinibWho this might be right forNon-Small Cell Lung Cancer With EGFR Mutation Abbisko Therapeutics Co, Ltd 54
Testing effectiveness (Phase 2)Study completedNCT00787761What this trial is testingEarly Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerWho this might be right forMyeloproliferative DisordersKidney CancerLeukemia+4 more Northside Hospital, Inc. 24
Early research (Phase 1)Ended earlyNCT00725062What this trial is testingDonor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Ended earlyNCT03325166What this trial is testingPembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain MetastasesWho this might be right forLung Carcinoma Metastatic in the BrainStage IV Lung Non-Small Cell Cancer AJCC v7 OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT00284141What this trial is testingStudy of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung AdenocarcinomaWho this might be right forPulmonary DiseasesNeoplasms, Lung Sanofi 98
Testing effectiveness (Phase 2)Study completedNCT00005854What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Fred Hutchinson Cancer Center
Not applicableStudy completedNCT02478294What this trial is testingLAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of StrokeWho this might be right forAtrial FibrillationStrokeSystemic Embolism The First Affiliated Hospital with Nanjing Medical University 474
Testing effectiveness (Phase 2)Study completedNCT00401570What this trial is testingVolociximab in Combination With Gemcitabine in Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer AbbVie (prior sponsor, Abbott) 40
Large-scale testing (Phase 3)UnknownNCT02387086What this trial is testingGefitinib Combined With Thalidomide to Treat NSCLCWho this might be right forNSCLC Bai Jun 380
Large-scale testing (Phase 3)Study completedNCT00389870What this trial is testingIrinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to FluorouracilWho this might be right forColorectal Cancer University of Leeds 1,198
Testing effectiveness (Phase 2)UnknownNCT02982486What this trial is testingA Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial CarcinomaWho this might be right forSoft Tissue SarcomaBone SarcomaChondrosarcoma+5 more Assaf-Harofeh Medical Center 60
Early research (Phase 1)Looking for participantsNCT06705686What this trial is testingNovel ACK1 Inhibitor (R)-9b in Patients With Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer (CRPC)Metastatic Castration-resistant Prostate Carcinoma TechnoGenesys, Inc. 40
Large-scale testing (Phase 3)Looking for participantsNCT06391242What this trial is testingStereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone MetastasesWho this might be right forCancer Metastatic Canadian Cancer Trials Group 230
Large-scale testing (Phase 3)Looking for participantsNCT06927986What this trial is testingPhase III Trial of SYS6010 Versus Platinum-based Chemotherapy for EGFR-mutated NSCLC（SYNSTAR01）Who this might be right forEGFR-mutated Locally Advanced or Metastatic NSCLC CSPC Megalith Biopharmaceutical Co.,Ltd. 380
Post-approval studies (Phase 4)Study completedNCT00770588What this trial is testingAssess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung Cancer (NSCLC) AstraZeneca 296
Early research (Phase 1)Study completedNCT01296139What this trial is testingFerumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI) 21